Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
Revenues | 1,144,352.4 | 238,489.0 | 177,536.0 | 128,074.0 | 94,054.0 | 75,925.0 | 59,792.0 | 50,767.0 |
Revenue growth | 379.8% | 34.3% | 38.6% | 36.2% | 23.9% | 27.0% | 17.8% | 28.5% |
Cost of goods sold | 176,293.4 | 85,734.0 | 55,788.0 | 35,893.0 | 23,952.0 | 19,754.0 | 16,810.0 | 14,336.0 |
Gross profit | 968,059.0 | 152,755.0 | 121,748.0 | 92,181.0 | 70,102.0 | 56,171.0 | 42,982.0 | 36,431.0 |
Gross margin | 84.6% | 64.1% | 68.6% | 72.0% | 74.5% | 74.0% | 71.9% | 71.8% |
Selling, general and administrative | 124,578.7 | 62,913.0 | 50,295.0 | 36,206.0 | 27,155.0 | 17,885.0 | 11,601.0 | 7,782.0 |
Research and development | 49,113.3 | 36,339.0 | 29,209.0 | 22,579.0 | 18,866.0 | 15,832.0 | 13,421.0 | 8,842.0 |
EBITA | 18,384.2 | 36,551.0 | 24,049.0 | 51,196.0 | 15,303.0 | 14,799.0 | 11,763.0 | 16,327.0 |
EBITA margin | 1.6% | 15.3% | 13.5% | 40.0% | 16.3% | 19.5% | 19.7% | 32.2% |
Amortization of intangibles | 6,029.1 | 3,825.0 | 2,613.0 | 2,304.0 | 2,108.0 | 1,952.0 | 1,594.0 | 1,004.0 |
EBIT | 12,355.1 | 32,726.0 | 21,436.0 | 48,892.0 | 13,195.0 | 12,847.0 | 10,169.0 | 15,323.0 |
EBIT margin | 1.1% | 13.7% | 12.1% | 38.2% | 14.0% | 16.9% | 17.0% | 30.2% |
Pre-tax income | -97.2 | 36,543.0 | 22,721.0 | 52,459.0 | 14,097.0 | 11,107.0 | 13,596.0 | 22,475.0 |
Income taxes | 22,590.0 | 13,193.0 | 11,656.0 | 8,201.0 | 5,016.0 | 4,324.0 | 3,917.0 | 5,455.0 |
Tax rate | | 36.1% | 51.3% | 15.6% | 35.6% | 38.9% | 28.8% | 24.3% |
Net income | -14,866.4 | 24,713.0 | 12,692.0 | 45,984.0 | 9,201.0 | 6,798.0 | 9,679.0 | 17,020.0 |
Net margin | -1.3% | 10.4% | 7.1% | 35.9% | 9.8% | 9.0% | 16.2% | 33.5% |
|
Diluted EPS | ($41.02) | $69.93 | $37.84 | $137.20 | $27.78 | $20.84 | $29.90 | $52.27 |
Shares outstanding (diluted) | 362.4 | 353.4 | 335.4 | 335.2 | 331.2 | 326.1 | 323.7 | 325.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|